Paxlovid Boceprevir Intermediate CAS 565456-77-1 Intende ≥99.0%

Description:

Nomen: (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acidum Methyl Ester hydrochloridum

CAS: 565456-77-1

Aspectus: Alba ad Off-White pulveris

Dic: ≥99.0%

Intermedium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0);

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acidum Methyl Ester hydrochloridum
Synonyma Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylatus hydrochloride
CAS Number 56545-77-1
CATTUS Number RF-PI318
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C9H15NO2.ClH
M. Pondus 205.683
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba ad Off-White pulveris
Lepidium sativum IR: Similia Reference substantia
Lepidium sativum B * Retention tempus: Similia Reference substantia
Enantiomer ≤0.15%
Related immunditiam (per HPLC)
Ignota immunditia ≤0.20%
Totalis immunditias ≤1.0%
Aqua ≤0.50%
Residere in Ignition ≤0.10%
Metalla gravis ≤20ppm
Assay ≥99.0%
Test Standard Enterprise Standard
Consuetudinem Intermedium PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0);

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

Applicatio:

(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylicus acidum Methyl Ester hydrochloridum (CAS 565456-77-1) est derivativum azabicyclohexanum in praeparatione hepatitis C adhibitum. virus (HCV) NS3 serine protease inhibitor.Medium illud est PF-07321332 Paxlovid (CAS 2628280-40-8) et Boceprevir (CAS 394730-60-0).PF-07321332 potens et viva voce SARS-CoV 3C sicut protease (3CLPRO) inhibitor.PF-07321332 scuta ad virum SARS-CoV-2 et pro COVID-19 reseacrch adhiberi possunt.Boceprevir (INN, nomen artis Victrelis) est protease inhibitor adhibitus ut curatio hepatitis C genotypi 1. Ligat ad HCV instructura 3 NS3 (HCV) situs activus.Proventus a Schering-Pough erat, sed nunc a Merck cum Schering anno 2009 acquiritur. Probatum est a FDA die 13 mensis Maii anno 2011 .

Epistulam tuam hic scribe et mitte nobis